Artificial intelligence (AI) is revolutionizing the diagnosis and management of inflammatory bowel disease (IBD), addressing long-standing challenges like diagnostic inconsistency and subjective disease scoring. By leveraging machine learning and advanced imaging, AI enhances endoscopic precision, improves histopathological analysis, and aids in disease monitoring, offering unprecedented accuracy and predictive capabilities. Emerging tools, such as AI-assisted cumulative disease scoring and real-time imaging analysis, promise to transform patient care by standardizing assessments and enabling more targeted treatments.
AI for IBD: Will Emerging Technology Revolutionize Care? (Gastroenterology Advisor)
0